Position in RPRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$7,539,780
+$4,826,789 QoQ
Shares Held
157,177
+123.9% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CenterBook Partners LP holds $104,676,185 across 36 Biotechnology names. RPRX ranks #4 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
171,166 | $15,213,234 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
150,912 | $11,331,982 | |
| 3 | ARGX |
Argenx SE
|
13,934 | $10,175,303 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
157,177 | $7,539,780 | |
| 5 | INSM |
INSMED Inc
|
35,232 | $5,761,136 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
157,122 | $4,668,094 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,060 | $3,909,558 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
97,003 | $3,902,430 |
All Filings in RPRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,539,780 | 157,177 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,712,991 | 70,212 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $3,115,788 | 88,316 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $5,729,562 | 159,022 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,961,407 | 63,007 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,671,789 | 104,735 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,174,575 | 218,260 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||